资讯

University of California, Los Angeles and University of California, San Diego researchers developed an injectable sealant for ...
The Milan Cell and Gene Center of Excellence at AGC Biologics will produce LVV material for Treg cell therapy candidates.
AGC Biologics has partnered with Quell Therapeutics to support the development of multiple Treg cell therapy drug candidates.
A joint research team affiliated with UNIST has developed a 3D-printed artificial tumor tissue capable of replicating the in ...
ADRX-0706 has received FDA fast track designation for the treatment of metastatic or locally advanced squamous cell cervical ...
Abstract Heterogeneity and the absence of a tumor microenvironment (TME) in traditional patient-derived organoid (PDO) cultures limit their ...
TB-500, a synthetic version of a naturally occurring peptide called Thymosin Beta-4 (Tβ4), has gained significant attention ...
New technique uses sound waves to separate precious fuel cell material for recycling and keep harmful ‘forever chemicals’ out ...
Venous thromboembolism (VTE), comprising deep vein thrombosis and pulmonary embolism, is a major cause of morbidity and ...
Cadherin 17 (CDH17) is a membrane-bound cell adhesion molecule involved in tumor cell proliferation and is selectively overexpressed in several gastrointestinal malignancies, including colorectal ...